NTRA logo Natera : NTRA

NTRA

Stock Data

$212.07

Change down

$7.16 (3.27%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Natera Inc is a pioneering diagnostics company that offers a wide range of molecular testing services globally. Its innovative portfolio includes Panorama, a non-invasive prenatal test for chromosomal abnormalities, and Horizon, a carrier screening test. Natera also provides Vistara, Spectrum, Anora, Empower, and a non-invasive prenatal paternity product. Additionally, it offers Signatera for cancer recurrence monitoring, Altera for genomic profiling, Prospera for transplant rejection assessment, and Renasight for kidney gene panel testing. Natera enhances its offerings through partnerships and a cloud-based software, Constellation, facilitating access to its advanced algorithms and bioinformatics. Founded in 2003, Natera is headquartered in Austin, Texas.

All Natera Articles

11 Articles